Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2023, 25, 130

Authors

Laura Riboni (ORCID: https://orcid.org/0000-0002-4149-8226)
Laura Guarnaccia (ORCID: https://orcid.org/0000-0002-5909-0165)
E Garzia
Antonella Ampollini
Giovanni Marfia (ORCID: https://orcid.org/0000-0002-5849-7000)
M Locatelli
Stefania Elena Navone (ORCID: https://orcid.org/0000-0002-0097-9146)
Rolando Campanella (ORCID: https://orcid.org/0000-0001-8382-1776)
Aniello Violetti
Laura Begani
Emanuela Barilla
Giovanni Alotta
Massimiliano D. Rizzaro
Manuela Caroli
Noreen Gervasi (ORCID: https://orcid.org/0000-0003-2862-1565)

Institutions

Advanced Cell Technology (United States) (US)
University of Milan (IT)
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
Ospedale Maggiore (IT)
Ospedale San Paolo (IT)
Embassy of Canada in Washington, D.C (US)
Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo

Publication Details

Journal: International Journal of Molecular Sciences
Published: 2026-05-12
DOI: https://doi.org/10.3390/ijms27104293
Primary Topic: Sphingolipid Metabolism and Signaling
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Fondazione Cariplo
Ministero della Salute

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2023, 25, 130

Laura Riboni, Laura Guarnaccia, E Garzia, Antonella Ampollini et al.

May 12, 2026

International Journal of Molecular Sciences

Sphingolipid Metabolism and Signaling

article

Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2023, 25, 130

Laura Riboni, Laura Guarnaccia, E Garzia, Antonella Ampollini, Giovanni Marfia, M Locatelli, Stefania Elena Navone, Rolando Campanella, Aniello Violetti, Laura Begani, Emanuela Barilla, Giovanni Alotta, Massimiliano D. Rizzaro, Manuela Caroli, Noreen Gervasi

May 12, 2026article en

Abstract

No abstract available for this paper.

International Journal of Molecular SciencesVol. 27(10)

Advanced Cell Technology (United States) (US), University of Milan (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Ospedale Maggiore (IT), Ospedale San Paolo (IT), Embassy of Canada in Washington, D.C (US), Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo

Fondazione Cariplo, Ministero della Salute

Zero hunger

Openalex Percentile: Top 9%

Sphingolipid Metabolism and Signaling

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2023, 25, 130 — Laura Riboni, Laura Guarnaccia, et al. · International Journal of Molecular Sciences (2026) | TGRS Research Map | TGRS